Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2
Opriessnig, Tanja, Gerber, Priscilla F., Xiao, Chao-Ting, Halbur, Patrick G., Matzinger, Shannon R., Meng, Xiang-JinVolume:
32
Language:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2014.06.004
Date:
July, 2014
File:
PDF, 937 KB
english, 2014